Candel Therapeutics, Inc.

Biotechnology company · Needham, Massachusetts, United States · Nasdaq: CADL

Candel Therapeutics, Inc. is a biotechnology company headquartered in Needham, Massachusetts, United States. Its shares trade on Nasdaq under the ticker CADL.

Profile compiled from public records. Is this your company? Request a correction or update

Candel Therapeutics at a glance

Typebiotechnology company

HeadquartersNeedham, Massachusetts, United States

Stock listingNasdaq: CADL

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1841387

Frequently asked questions about Candel Therapeutics

Where is Candel Therapeutics headquartered?

Candel Therapeutics, Inc. is headquartered in Needham, Massachusetts, United States.

What does Candel Therapeutics do?

Candel Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Candel Therapeutics a public company?

Yes. Candel Therapeutics, Inc. trades on Nasdaq under the ticker CADL.

Similar companies

Avant Immunotherapeutics, Inc.Needham, Massachusetts, United States
Stemetix, Inc.Needham, Massachusetts, United States
Remedium Bio Inc.Needham, Massachusetts, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences